$NERX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PONIARD PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PONIARD PHARMACEUTICALS, INC.. Get notifications about new insider transactions in PONIARD PHARMACEUTICALS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 27 2012 | NERX | PONIARD PHARMACEUT ... | PERRY MICHAEL S | President & CMO | Sell | S | 0.83 | 1,599 | 1,330 | 8,920 | 10.5 K to 8.9 K (-15.20 %) |
Mar 27 2012 | NERX | PONIARD PHARMACEUT ... | PERRY MICHAEL S | President & CMO | Option Exercise | M | 0.00 | 2,800 | 0 | 0 | |
Mar 27 2012 | NERX | PONIARD PHARMACEUT ... | PERRY MICHAEL S | President & CMO | Buy | M | 0.00 | 2,800 | 0 | 10,519 | 7.7 K to 10.5 K (+36.27 %) |
Mar 27 2012 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Interim CFO | Sell | S | 0.83 | 257 | 214 | 5,668 | 5.9 K to 5.7 K (-4.34 %) |
Feb 17 2012 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Interim CFO | Sell | S | 0.87 | 2,401 | 2,084 | 5,450 | 7.9 K to 5.5 K (-30.58 %) |
Mar 27 2012 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Interim CFO | Option Exercise | M | 0.00 | 475 | 0 | 0 | |
Mar 27 2012 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Interim CFO | Buy | M | 0.00 | 475 | 0 | 5,925 | 5.5 K to 5.9 K (+8.72 %) |
Feb 17 2012 | NERX | PONIARD PHARMACEUT ... | PERRY MICHAEL S | President & CMO | Sell | S | 0.87 | 6,346 | 5,508 | 7,719 | 14.1 K to 7.7 K (-45.12 %) |
Feb 17 2012 | NERX | PONIARD PHARMACEUT ... | PERRY MICHAEL S | President & CMO | Option Exercise | M | 0.00 | 12,019 | 0 | 0 | |
Feb 17 2012 | NERX | PONIARD PHARMACEUT ... | PERRY MICHAEL S | President & CMO | Buy | M | 0.00 | 12,019 | 0 | 14,065 | 2 K to 14.1 K (+587.44 %) |
Feb 17 2012 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Interim CFO | Option Exercise | M | 0.00 | 5,769 | 0 | 0 | |
Feb 17 2012 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Interim CFO | Buy | M | 0.00 | 5,769 | 0 | 7,851 | 2.1 K to 7.9 K (+277.09 %) |
Oct 07 2011 | NERX | PONIARD PHARMACEUT ... | MARTELL RON | Chief Executive Off ... | Option Exercise | M | 0.00 | 25,000 | 0 | 50,000 | |
Oct 07 2011 | NERX | PONIARD PHARMACEUT ... | MARTELL RON | Chief Executive Off ... | Buy | M | 0.00 | 25,000 | 0 | 548,073 | 523.1 K to 548.1 K (+4.78 %) |
Jul 12 2011 | NERX | PONIARD PHARMACEUT ... | LYONS GARY A | Director | Option Exercise | M | 0.00 | 85,000 | 0 | 0 | |
Jul 12 2011 | NERX | PONIARD PHARMACEUT ... | LYONS GARY A | Director | Buy | M | 0.00 | 85,000 | 0 | 206,145 | 121.1 K to 206.1 K (+70.16 %) |
Jun 10 2011 | NERX | PONIARD PHARMACEUT ... | BASSO ROBERT S | Director | Option Exercise | M | 0.00 | 36,145 | 0 | 36,144 | |
Jun 10 2011 | NERX | PONIARD PHARMACEUT ... | BASSO ROBERT S | Director | Buy | M | 0.00 | 36,145 | 0 | 41,145 | 5 K to 41.1 K (+722.90 %) |
Jun 10 2011 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Option Exercise | M | 0.00 | 36,145 | 0 | 36,144 | |
Jun 10 2011 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | M | 0.00 | 36,145 | 0 | 239,948 | 203.8 K to 239.9 K (+17.74 %) |
Jun 10 2011 | NERX | PONIARD PHARMACEUT ... | Littauer Robert K | Director | Option Exercise | M | 0.00 | 36,145 | 0 | 36,144 | |
Jun 10 2011 | NERX | PONIARD PHARMACEUT ... | Littauer Robert K | Director | Buy | M | 0.00 | 36,145 | 0 | 36,145 | 0 to 36.1 K |
Jun 10 2011 | NERX | PONIARD PHARMACEUT ... | DICKSON E ROLLAND | Director | Option Exercise | M | 0.00 | 11,928 | 0 | 11,927 | |
Jun 10 2011 | NERX | PONIARD PHARMACEUT ... | DICKSON E ROLLAND | Director | Option Exercise | M | 0.00 | 36,145 | 0 | 36,144 | |
Jun 10 2011 | NERX | PONIARD PHARMACEUT ... | DICKSON E ROLLAND | Director | Buy | M | 0.00 | 11,928 | 0 | 48,906 | 37 K to 48.9 K (+32.26 %) |
Jun 10 2011 | NERX | PONIARD PHARMACEUT ... | DICKSON E ROLLAND | Director | Buy | M | 0.00 | 36,145 | 0 | 36,978 | 833 to 37 K (+4,339.14 %) |
Jun 10 2011 | NERX | PONIARD PHARMACEUT ... | LYONS GARY A | Director | Option Exercise | M | 0.00 | 36,145 | 0 | 36,144 | |
Jun 10 2011 | NERX | PONIARD PHARMACEUT ... | LYONS GARY A | Director | Buy | M | 0.00 | 36,145 | 0 | 121,145 | 85 K to 121.1 K (+42.52 %) |
Jun 10 2011 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Director | Option Exercise | M | 0.00 | 18,073 | 0 | 18,072 | |
Jun 10 2011 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Director | Option Exercise | M | 0.00 | 36,145 | 0 | 36,144 | |
Jun 10 2011 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Director | Buy | M | 0.00 | 18,073 | 0 | 73,826 | 55.8 K to 73.8 K (+32.42 %) |
Jun 10 2011 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Director | Buy | M | 0.00 | 36,145 | 0 | 55,753 | 19.6 K to 55.8 K (+184.34 %) |
Jun 10 2011 | NERX | PONIARD PHARMACEUT ... | Stevens David R | Director | Option Exercise | M | 0.00 | 36,145 | 0 | 36,144 | |
Jun 10 2011 | NERX | PONIARD PHARMACEUT ... | Stevens David R | Director | Buy | M | 0.00 | 36,145 | 0 | 55,963 | 19.8 K to 56 K (+182.38 %) |
Jun 10 2011 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Option Exercise | M | 0.00 | 36,145 | 0 | 36,144 | |
Jun 10 2011 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Buy | M | 0.00 | 36,145 | 0 | 39,478 | 3.3 K to 39.5 K (+1,084.46 %) |
Apr 14 2011 | NERX | PONIARD PHARMACEUT ... | PERRY MICHAEL S | President & CMO | Sell | S | 0.37 | 45,140 | 16,864 | 81,860 | 127 K to 81.9 K (-35.54 %) |
Apr 14 2011 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Interim CFO | Sell | S | 0.37 | 7,655 | 2,860 | 83,312 | 91 K to 83.3 K (-8.42 %) |
Apr 12 2011 | NERX | PONIARD PHARMACEUT ... | PERRY MICHAEL S | President & CMO | Option Exercise | M | 0.00 | 112,000 | 0 | 112,000 | |
Apr 12 2011 | NERX | PONIARD PHARMACEUT ... | PERRY MICHAEL S | President & CMO | Buy | M | 0.00 | 112,000 | 0 | 127,000 | 15 K to 127 K (+746.67 %) |
Apr 12 2011 | NERX | PONIARD PHARMACEUT ... | MARTELL RON | Chief Executive Off ... | Option Exercise | M | 0.00 | 162,500 | 0 | 162,500 | |
Apr 12 2011 | NERX | PONIARD PHARMACEUT ... | MARTELL RON | Chief Executive Off ... | Buy | M | 0.00 | 162,500 | 0 | 523,073 | 360.6 K to 523.1 K (+45.07 %) |
Apr 12 2011 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Interim CFO | Option Exercise | M | 0.00 | 19,000 | 0 | 19,000 | |
Apr 12 2011 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Interim CFO | Buy | M | 0.00 | 19,000 | 0 | 90,967 | 72 K to 91 K (+26.40 %) |
Feb 16 2011 | NERX | PONIARD PHARMACEUT ... | PERRY MICHAEL S | President & CMO | Option Exercise | A | 0.00 | 480,770 | 0 | 480,770 | |
Mar 15 2011 | NERX | PONIARD PHARMACEUT ... | PERRY MICHAEL S | President & CMO | Option Exercise | A | 0.00 | 224,000 | 0 | 224,000 | |
Feb 16 2011 | NERX | PONIARD PHARMACEUT ... | MARTELL RON | Chief Executive Off ... | Option Exercise | A | 0.00 | 576,924 | 0 | 576,924 | |
Feb 16 2011 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Interim CFO | Option Exercise | A | 0.00 | 230,770 | 0 | 230,770 | |
Feb 08 2011 | NERX | PONIARD PHARMACEUT ... | MARTELL RON | Chief Executive Off ... | Option Exercise | M | 0.00 | 31,250 | 0 | 93,750 | |
Feb 08 2011 | NERX | PONIARD PHARMACEUT ... | MARTELL RON | Chief Executive Off ... | Buy | M | 0.00 | 31,250 | 0 | 360,573 | 329.3 K to 360.6 K (+9.49 %) |
Jan 12 2011 | NERX | PONIARD PHARMACEUT ... | MARTELL RON | Chief Executive Off ... | Option Exercise | M | 0.00 | 25,000 | 0 | 75,000 | |
Jan 12 2011 | NERX | PONIARD PHARMACEUT ... | MARTELL RON | Chief Executive Off ... | Buy | M | 0.00 | 25,000 | 0 | 329,323 | 304.3 K to 329.3 K (+8.21 %) |
Jan 07 2011 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Interim CFO | Sell | S | 0.52 | 44,816 | 23,412 | 71,967 | 116.8 K to 72 K (-38.38 %) |
Jan 04 2011 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Principal Accountin ... | Option Exercise | M | 0.00 | 105,391 | 0 | 0 | |
Jan 04 2011 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Principal Accountin ... | Buy | M | 0.00 | 105,391 | 0 | 116,783 | 11.4 K to 116.8 K (+925.13 %) |
Jan 04 2011 | NERX | PONIARD PHARMACEUT ... | MARTELL RON | Chief Executive Off ... | Option Exercise | M | 0.00 | 292,208 | 0 | 0 | |
Jan 04 2011 | NERX | PONIARD PHARMACEUT ... | MARTELL RON | Chief Executive Off ... | Buy | M | 0.00 | 292,208 | 0 | 304,323 | 12.1 K to 304.3 K (+2,411.95 %) |
Aug 03 2010 | NERX | PONIARD PHARMACEUT ... | PERRY MICHAEL S | President & CMO | Grant | A | 0.00 | 7,500 | 0 | 15,000 | 7.5 K to 15 K (+100.00 %) |
Jul 12 2010 | NERX | PONIARD PHARMACEUT ... | LYONS GARY A | Director | Buy | M | 0.00 | 85,000 | 0 | 85,000 | 0 to 85 K |
Jun 11 2010 | NERX | PONIARD PHARMACEUT ... | SIMON NICHOLAS J III | Director | Grant | A | 0.00 | 72,289 | 0 | 72,289 | 0 to 72.3 K |
Jun 11 2010 | NERX | PONIARD PHARMACEUT ... | LYONS GARY A | Director | Option Exercise | A | 0.00 | 72,289 | 0 | 72,289 | |
Jun 11 2010 | NERX | PONIARD PHARMACEUT ... | Stevens David R | Director | Option Exercise | A | 0.00 | 72,289 | 0 | 72,289 | |
Jun 11 2010 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Director | Option Exercise | A | 0.00 | 36,145 | 0 | 36,145 | |
Jun 11 2010 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Director | Option Exercise | A | 0.00 | 72,289 | 0 | 72,289 | |
Jun 11 2010 | NERX | PONIARD PHARMACEUT ... | Littauer Robert K | Director | Option Exercise | A | 0.00 | 72,289 | 0 | 72,289 | |
Jun 11 2010 | NERX | PONIARD PHARMACEUT ... | DICKSON E ROLLAND | Director | Option Exercise | A | 0.00 | 23,855 | 0 | 23,855 | |
Jun 11 2010 | NERX | PONIARD PHARMACEUT ... | DICKSON E ROLLAND | Director | Option Exercise | A | 0.00 | 72,289 | 0 | 72,289 | |
Jun 11 2010 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Option Exercise | A | 0.00 | 72,289 | 0 | 72,289 | |
Jun 11 2010 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Option Exercise | A | 0.00 | 72,289 | 0 | 72,289 | |
Jun 11 2010 | NERX | PONIARD PHARMACEUT ... | BASSO ROBERT S | Director | Option Exercise | A | 0.00 | 72,289 | 0 | 72,289 | |
Jun 11 2010 | NERX | PONIARD PHARMACEUT ... | MARTELL RON | Chief Executive Off ... | Option Exercise | A | 0.00 | 250,000 | 0 | 250,000 | |
Apr 21 2010 | NERX | PONIARD PHARMACEUT ... | PERRY MICHAEL S | President & CMO | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
Apr 13 2010 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Principal Accountin ... | Option Exercise | A | 0.00 | 38,000 | 0 | 256,070 | |
Apr 13 2010 | NERX | PONIARD PHARMACEUT ... | MARTELL RON | Chief Executive Off ... | Option Exercise | A | 0.00 | 325,000 | 0 | 1,675,541 | |
Mar 29 2010 | NERX | PONIARD PHARMACEUT ... | MARTELL RON | Chief Executive Off ... | Buy | P | 1.24 | 10,915 | 13,535 | 12,115 | 1.2 K to 12.1 K (+909.58 %) |
Mar 29 2010 | NERX | PONIARD PHARMACEUT ... | MARTELL RON | Chief Executive Off ... | Buy | P | 1.26 | 1,200 | 1,512 | 1,200 | 0 to 1.2 K |
Feb 09 2010 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Principal Accountin ... | Grant | A | 0.00 | 11,056 | 0 | 237,887 | 226.8 K to 237.9 K (+4.87 %) |
Feb 09 2010 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Principal Accountin ... | Sell | S | 1.62 | 3,669 | 5,939 | 234,218 | 237.9 K to 234.2 K (-1.54 %) |
Feb 08 2010 | NERX | PONIARD PHARMACEUT ... | WEAVER GREGORY L | Chief Financial Off ... | Option Exercise | A | 0.00 | 188,312 | 0 | 398,312 | |
Feb 08 2010 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Principal Accountin ... | Option Exercise | A | 0.00 | 105,391 | 0 | 237,887 | |
Feb 08 2010 | NERX | PONIARD PHARMACEUT ... | MARTELL RON | Chief Executive Off ... | Option Exercise | A | 0.00 | 292,208 | 0 | 1,350,541 | |
Feb 08 2010 | NERX | PONIARD PHARMACEUT ... | PERRY MICHAEL S | President & CMO | Option Exercise | A | 1.60 | 500,000 | 800,000 | 515,000 | |
Nov 30 2009 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Principal Accountin ... | Sell | D | 2.23 | 751 | 1,675 | 4,005 | 4.8 K to 4 K (-15.79 %) |
Nov 09 2009 | NERX | PONIARD PHARMACEUT ... | SIMON NICHOLAS J III | Director | Sell | S | 8.50 | 152,052 | 1,292,442 | 6,363,249 | 6.5 M to 6.4 M (-2.33 %) |
Nov 09 2009 | NERX | PONIARD PHARMACEUT ... | SIMON NICHOLAS J III | Director | Sell | S | 8.06 | 264,648 | 2,132,560 | 6,515,301 | 6.8 M to 6.5 M (-3.90 %) |
Nov 09 2009 | NERX | PONIARD PHARMACEUT ... | SIMON NICHOLAS J III | Director | Sell | S | 8.00 | 78,262 | 626,292 | 6,779,949 | 6.9 M to 6.8 M (-1.14 %) |
Nov 17 2009 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Principal Accountin ... | Grant | A | 0.00 | 2,854 | 0 | 4,756 | 1.9 K to 4.8 K (+150.05 %) |
Nov 09 2009 | NERX | PONIARD PHARMACEUT ... | EVNIN LUKE | 10% Owner | Sell | S | 8.50 | 152,052 | 1,292,442 | 6,363,249 | 6.5 M to 6.4 M (-2.33 %) |
Nov 09 2009 | NERX | PONIARD PHARMACEUT ... | EVNIN LUKE | 10% Owner | Sell | S | 8.06 | 264,648 | 2,132,560 | 6,515,301 | 6.8 M to 6.5 M (-3.90 %) |
Nov 09 2009 | NERX | PONIARD PHARMACEUT ... | EVNIN LUKE | 10% Owner | Sell | S | 8.00 | 78,262 | 626,292 | 6,779,949 | 6.9 M to 6.8 M (-1.14 %) |
Nov 09 2009 | NERX | PONIARD PHARMACEUT ... | MPM BIOVENTURES III LLC | 10% Owner | Sell | S | 8.50 | 152,052 | 1,292,442 | 6,363,249 | 6.5 M to 6.4 M (-2.33 %) |
Nov 09 2009 | NERX | PONIARD PHARMACEUT ... | MPM BIOVENTURES III LLC | 10% Owner | Sell | S | 8.06 | 264,648 | 2,132,560 | 6,515,301 | 6.8 M to 6.5 M (-3.90 %) |
Nov 09 2009 | NERX | PONIARD PHARMACEUT ... | MPM BIOVENTURES III LLC | 10% Owner | Sell | S | 8.00 | 78,262 | 626,292 | 6,779,949 | 6.9 M to 6.8 M (-1.14 %) |
Oct 08 2009 | NERX | PONIARD PHARMACEUT ... | MARTELL RON | President & COO | Option Exercise | A | 0.00 | 100,000 | 0 | 1,058,333 | |
Aug 21 2009 | NERX | PONIARD PHARMACEUT ... | WEAVER GREGORY L | Chief Financial Off ... | Buy | P | 7.40 | 900 | 6,660 | 10,000 | 9.1 K to 10 K (+9.89 %) |
Aug 21 2009 | NERX | PONIARD PHARMACEUT ... | WEAVER GREGORY L | Chief Financial Off ... | Buy | P | 7.39 | 2,100 | 15,519 | 9,100 | 7 K to 9.1 K (+30.00 %) |
Jul 14 2009 | NERX | PONIARD PHARMACEUT ... | LYONS GARY A | Director | Option Exercise | A | 0.00 | 170,000 | 0 | 200,000 | |
Jul 09 2009 | NERX | PONIARD PHARMACEUT ... | LYONS GARY A | Director | Option Exercise | A | 6.69 | 30,000 | 200,700 | 30,000 | |
Jun 25 2009 | NERX | PONIARD PHARMACEUT ... | Stevens David R | Director | Option Exercise | A | 4.70 | 15,000 | 70,500 | 95,831 | |
Jun 25 2009 | NERX | PONIARD PHARMACEUT ... | SIMON NICHOLAS J III | Director | Option Exercise | A | 4.70 | 15,000 | 70,500 | 15,000 | |
Jun 25 2009 | NERX | PONIARD PHARMACEUT ... | Littauer Robert K | Director | Option Exercise | A | 4.70 | 15,000 | 70,500 | 95,831 | |
Jun 25 2009 | NERX | PONIARD PHARMACEUT ... | DICKSON E ROLLAND | Director | Option Exercise | A | 4.70 | 7,500 | 35,250 | 132,494 | |
Jun 25 2009 | NERX | PONIARD PHARMACEUT ... | DICKSON E ROLLAND | Director | Option Exercise | A | 4.70 | 15,000 | 70,500 | 124,994 | |
Jun 25 2009 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Option Exercise | A | 4.70 | 15,000 | 70,500 | 137,494 | |
Jun 25 2009 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Option Exercise | A | 4.70 | 15,000 | 70,500 | 109,161 | |
Jun 03 2009 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Principal Accountin ... | Grant | A | 0.00 | 951 | 0 | 1,902 | 951 to 1.9 K (+100.00 %) |
Jun 25 2009 | NERX | PONIARD PHARMACEUT ... | BASSO ROBERT S | Director | Option Exercise | A | 4.70 | 15,000 | 70,500 | 60,000 | |
Apr 07 2009 | NERX | PONIARD PHARMACEUT ... | BASSO ROBERT S | Director | Buy | P | 2.05 | 5,000 | 10,250 | 5,000 | 0 to 5 K |
Apr 06 2009 | NERX | PONIARD PHARMACEUT ... | WEAVER GREGORY L | Chief Financial Off ... | Buy | P | 2.10 | 225 | 473 | 7,000 | 6.8 K to 7 K (+3.32 %) |
Apr 06 2009 | NERX | PONIARD PHARMACEUT ... | WEAVER GREGORY L | Chief Financial Off ... | Buy | P | 2.07 | 1,575 | 3,260 | 6,775 | 5.2 K to 6.8 K (+30.29 %) |
Apr 06 2009 | NERX | PONIARD PHARMACEUT ... | WEAVER GREGORY L | Chief Financial Off ... | Buy | P | 2.05 | 200 | 410 | 5,200 | 5 K to 5.2 K (+4.00 %) |
Apr 03 2009 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Principal Accountin ... | Grant | A | 0.00 | 951 | 0 | 951 | 0 to 951 |
Mar 30 2009 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 2.14 | 1,200 | 2,568 | 203,803 | 202.6 K to 203.8 K (+0.59 %) |
Mar 30 2009 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 2.13 | 100 | 213 | 202,603 | 202.5 K to 202.6 K (+0.05 %) |
Mar 30 2009 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 2.15 | 3,300 | 7,095 | 202,503 | 199.2 K to 202.5 K (+1.66 %) |
Mar 30 2009 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 2.12 | 400 | 848 | 199,203 | 198.8 K to 199.2 K (+0.20 %) |
Mar 30 2009 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 2.15 | 2,600 | 5,590 | 198,803 | 196.2 K to 198.8 K (+1.33 %) |
Mar 30 2009 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 2.13 | 800 | 1,704 | 196,203 | 195.4 K to 196.2 K (+0.41 %) |
Mar 30 2009 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 2.12 | 1,500 | 3,180 | 195,403 | 193.9 K to 195.4 K (+0.77 %) |
Mar 30 2009 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 2.10 | 3,400 | 7,140 | 193,903 | 190.5 K to 193.9 K (+1.78 %) |
Mar 30 2009 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 2.09 | 1,900 | 3,971 | 190,503 | 188.6 K to 190.5 K (+1.01 %) |
Mar 30 2009 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 2.08 | 1,700 | 3,536 | 188,603 | 186.9 K to 188.6 K (+0.91 %) |
Mar 30 2009 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 2.07 | 1,300 | 2,691 | 186,903 | 185.6 K to 186.9 K (+0.70 %) |
Mar 30 2009 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 2.06 | 1,300 | 2,678 | 185,603 | 184.3 K to 185.6 K (+0.71 %) |
Mar 30 2009 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 2.05 | 500 | 1,025 | 184,303 | 183.8 K to 184.3 K (+0.27 %) |
Feb 19 2009 | NERX | PONIARD PHARMACEUT ... | WEAVER GREGORY L | Chief Financial Off ... | Option Exercise | A | 2.38 | 200,000 | 476,000 | 200,000 | |
Jan 13 2009 | NERX | PONIARD PHARMACEUT ... | Stevens David R | Director | Buy | P | 3.45 | 1,850 | 6,383 | 19,818 | 18 K to 19.8 K (+10.30 %) |
Jan 13 2009 | NERX | PONIARD PHARMACEUT ... | Stevens David R | Director | Buy | P | 3.44 | 500 | 1,720 | 17,968 | 17.5 K to 18 K (+2.86 %) |
Jan 13 2009 | NERX | PONIARD PHARMACEUT ... | Stevens David R | Director | Buy | P | 3.43 | 3,800 | 13,034 | 17,468 | 13.7 K to 17.5 K (+27.80 %) |
Jan 13 2009 | NERX | PONIARD PHARMACEUT ... | Stevens David R | Director | Buy | P | 3.41 | 100 | 341 | 13,668 | 13.6 K to 13.7 K (+0.74 %) |
Jan 13 2009 | NERX | PONIARD PHARMACEUT ... | Stevens David R | Director | Buy | P | 3.40 | 200 | 680 | 13,568 | 13.4 K to 13.6 K (+1.50 %) |
Dec 31 2008 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Chief Executive Off ... | Buy | P | 1.30 | 4,300 | 5,590 | 19,608 | 15.3 K to 19.6 K (+28.09 %) |
Dec 31 2008 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Chief Executive Off ... | Buy | P | 1.29 | 2,200 | 2,838 | 15,308 | 13.1 K to 15.3 K (+16.78 %) |
Dec 31 2008 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Chief Executive Off ... | Buy | P | 1.28 | 900 | 1,152 | 13,108 | 12.2 K to 13.1 K (+7.37 %) |
Dec 31 2008 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Chief Executive Off ... | Buy | P | 1.27 | 100 | 127 | 12,208 | 12.1 K to 12.2 K (+0.83 %) |
Dec 30 2008 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Chief Executive Off ... | Buy | P | 1.40 | 7,375 | 10,325 | 12,108 | 4.7 K to 12.1 K (+155.82 %) |
Dec 23 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.81 | 600 | 1,086 | 143,200 | 142.6 K to 143.2 K (+0.42 %) |
Dec 23 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.80 | 1,000 | 1,800 | 142,600 | 141.6 K to 142.6 K (+0.71 %) |
Dec 23 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.79 | 300 | 537 | 141,600 | 141.3 K to 141.6 K (+0.21 %) |
Dec 23 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.68 | 1,000 | 1,680 | 141,300 | 140.3 K to 141.3 K (+0.71 %) |
Dec 23 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.86 | 500 | 930 | 140,300 | 139.8 K to 140.3 K (+0.36 %) |
Dec 23 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.84 | 300 | 552 | 139,800 | 139.5 K to 139.8 K (+0.22 %) |
Dec 23 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.82 | 200 | 364 | 139,500 | 139.3 K to 139.5 K (+0.14 %) |
Dec 23 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.81 | 900 | 1,629 | 139,300 | 138.4 K to 139.3 K (+0.65 %) |
Dec 23 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.80 | 2,400 | 4,320 | 138,400 | 136 K to 138.4 K (+1.76 %) |
Dec 23 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.79 | 1,400 | 2,506 | 136,000 | 134.6 K to 136 K (+1.04 %) |
Dec 23 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.78 | 900 | 1,602 | 134,600 | 133.7 K to 134.6 K (+0.67 %) |
Dec 23 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.77 | 1,500 | 2,655 | 133,700 | 132.2 K to 133.7 K (+1.13 %) |
Dec 23 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.76 | 500 | 880 | 132,200 | 131.7 K to 132.2 K (+0.38 %) |
Dec 23 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.75 | 3,800 | 6,650 | 131,700 | 127.9 K to 131.7 K (+2.97 %) |